ODI is a small business working to bring big ideas for improved non-invasive measurement of metabolic health to market using the latest cloud computing technologies.
The ODI technology concept is to unify metabolic function assessment with cardiopulmonary fitness assessment for cardio-metabolic assessment and forecasting through mathematical modeling.
ODI has published papers regarding its self-adapting statistical mathematical models of the human energy metabolism, which are the core of its technology [1-7].
ODI research and development in cardio-metabolic assessment has resulted in a patented method for noninvasive measurement and predication using its self-adapting statistical mathematical models of the impossible or difficult to measure parameters of the metabolism of the user, with the goal to allow the user to achieve a desired body composition outcome [8,9].
The embodiment of ODI research and development is the ODI metabolic health monitoring system, ORI FIT-MET™. ORI FIT-MET™ extracts measured data from wearable device sensors and can be used for tracking the estimated daily utilized macronutrient energy intake, macronutrient oxidation rate, daily changes of fat weight, lean body mass, and insulin resistance of the user [1-7].
Aim: The goal is to show the feasibility of mobile computing to help users reach and maintain metabolic health. The physical components include a smart watch with appropriate sensors, smart phone, and bathroom scale with fat weight measuring capabilities. The software components are connected through cloud computing. The metabolic health monitoring app is performing data gathering. The results display metabolic trends and makes predictions regarding changes of fat mass, lean body mass, insulin resistance changes by the Rw-ratio, and 24-hour non-protein respiratory quotient, as well as the utilized macronutrient intake and oxidation rates.
Method: We performed a meta-analysis of published clinical trial data which recorded changes of weight, fat weight and pre- and post-intervention markers of insulin resistance (HOMA-IR). We calculated the absolute change by the Rw-ratio over time (defined as the ratio of whole-body mass change velocity to fat mass change velocity) in 40 studies from 12 clinical trials and correlated this with the percent change ∆H% of the HOMA-IR across all studies, which were included into the meta-analysis.
Results: We found excellent correlation between Rw and ∆H% of -0.8510, P=0.0036. The correlation between weight change W and ∆H% was 0.8929 with P=0.0012; fat mass change F and ∆H% was 0.7915 with P=0.0011.
Conclusions: Utilizing principles of indirect calorimetry and serial measurements of fat, weight, and energy balance estimates, we found at steady state energy balance status significant correlation between change of insulin resistance measured with HOMA-IR and changes of Rw-ratio, weight, fat weight, and fat oxidation fraction. The implication of these results is also that insulin resistance has a measurable and quantifiable relationship with the energy metabolism, allowing for the prediction of insulin resistance and fat oxidation changes from serial measurements of weight and fat mass. Serial fat and weight measurements and energy calculations can help unmask insulin resistance related metabolic changes, such as metabolic inflexibility and impaired fat oxidation.
References
[3] Ori Z. Dynamic Indirect Measurement of the Daily Macronutrient Oxidation Rate, Changes of Fat and Fat Free Mass. Poster session presented at: Innovation at the Interface. 2015 BMES Annual Meeting; 2015 Oct 7-10; Tampa, FL.
[6] Őri, Z: The Predictability of Insulin Resistance and Fat Oxidation Changes from Serial Measurements of Weight and Fat Mass. Annual Scientific Meeting in Sarasota, Florida of the Hungarian Medical Association of America, October 28-November 2, in Archives of the Hungarian Medical Association of America (ISSN 1070-0773), 2018, Vol. 26, No3, p 92.
[7] Ori, Z: Cyber-Physical System for Management and Self-Management of Cardio-metabolic Health. Published on-line and accepted for publication in “Type 2 Diabetes” by IntechOpen, DOI: http://dx.doi.org/10.5772/intechopen.84262
[8] Ori Z; Ori Diagnostic Instruments, LLC, assignee. "An Apparatus and Method for the Analysis of the Change of Body Composition and Hydration Status and for Dynamic Indirect Individualized Measurement of Components of the Human Energy Metabolism," U.S. Patent No.: 9,949,663 B1 Date: 4/24/2018, U.S. Patent No.: 10,716,491 B2 Date: 7/21/2020
[10] Ori, Z: Metabolic Health Analysis and Forecasting with Mobile Computing. Published on-line and accepted for publication in “Mobile Computing” by IntechOpen, DOI: 10.5772/intechopen.88872
Copyright © 2023 Ori Diagnostic Instruments, L.L.C. - All Rights Reserved.